Heliyon (Sep 2024)

Current insights and future directions of LncRNA Morrbid in disease pathogenesis

  • Haiqiong Yang,
  • Jiali Gao,
  • Zaiyong Zheng,
  • Yang Yu,
  • Chunxiang Zhang

Journal volume & issue
Vol. 10, no. 17
p. e36681

Abstract

Read online

Non-coding RNAs have emerged as important regulators of gene expression and contributors to many diseases. LncRNA Morrbid, a long non-coding RNA, has been widely studied in recent years. Current literature reports that lncRNA Morrbid is involved in various diseases such as tumors, cardiovascular diseases, inflammatory diseases and metabolic disorder. However, controversial conclusions exist in current studies. As a potential therapeutic target, it is necessary to comprehensively review the current evidence. In this work, we carefully review the literature on Morrbid and discuss each of the hot topics related to lncRNA Morrbid.

Keywords